Meenal Gehlawat, MD

Resident doctor training in Internal Medicine| Sharing pearls from residency

[Meenal Gehlawat, MD @GehlawatM]

@AlejaMolina Thank you @AlejaMolina

[Meenal Gehlawat, MD @GehlawatM]

I am thrilled to share that I won 1st Prize at the ACP 2026 Poster Competition for our study on opioid disparities! 🏆

#ACP2026 #MedicalResearch #DVH

[Meenal Gehlawat, MD @GehlawatM]

@sumanbiswasmd Thanks @sumanbiswasmd

[Meenal Gehlawat, MD @GehlawatM]

Presenting our latest work at SOHO 2026!

[Nature Medicine @NatureMedicine]

From the MajesTEC-5 trial, induction with teclistamab followed by daratumumab + lenalidomide has a comparable toxicity profile to other regimens, with encouraging response rates in newly diagnosed multiple myeloma.

@RaabMarc @RascheLeo @HDMyeloma #mmsm

https://t.co/p4Bi05hcwG

[Meenal Gehlawat, MD @GehlawatM]

Empowering our community through preventative care! Dr. Shah and I had a fantastic, highly interactive session leading a health screening workshop at the local senior wellness center.
#IMresidency #residentlife #communityhealth

[Meenal Gehlawat, MD @GehlawatM]

Loved leading Journal Club discussion on a classic clinical dilemma: liberal vs. restrictive transfusion strategies.
Huge thanks to everyone who brought their sharp insights and tough questions to the table today!
#residentlife #medtwitter #medicine

[PanCAN @PanCAN]

We’re grateful to see @SenWhitehouse, a longtime congressional champion for #pancreaticcancer research, highlighting the recent #daraxonrasib news. 💊

Breakthroughs like daraxonrasib are possible because of sustained and increased investments in #cancer research and landmark efforts like the Recalcitrant Cancer Research Act, which helped drive greater focus on one of the nation’s deadliest cancers.

This progress demonstrates what’s possible when patients, PanCAN advocates, researchers and Congress work together. While there is still much more to do, PanCAN is proud to work alongside champions like Senator Whitehouse as we advocate for the continued federal investment needed to advance innovation and bring more effective treatment options to patients facing pancreatic cancer.

[Pashtoon Kasi MD, MS @pashtoonkasi]

🆕@JCOPO_ASCO
💡Such a beautiful story of real world🌎 precision medicine.

Meet➡️#ERRFI1🎯

📝Time to add➕this to ACTIONABLE Biomarkers🔐for #cholanagiocarcinoma @curecc. @NCCN

👇🏽Patient in paper, I took off hospice to give Erlotinib💊.

@OncoAlert

🔗https://t.co/09PD5QHv0s

[Meenal Gehlawat, MD @GehlawatM]

Had an amazing experience presenting our research at #ASCO2026
Immensely grateful for the opportunity to represent my program during my intern year. Thankful to my team, mentors and everyone who stopped by🙏🏻
#medTwitter #OncTwitter #PGY-1 #DesertValleyHospital

[Meenal Gehlawat, MD @GehlawatM]

Exciting day, sharing our latest research poster! Always an honor to represent Desert Valley Hospital. #MedTwitter #InternalMedicine #PGY-1 #Residentlife #DesertValleyHospital

[Meenal Gehlawat, MD @GehlawatM]

Honored to have presented our research at #CUSM #ARMC Annual Research Symposium and incredibly grateful to receive a podium presentation award! 🏆 Huge thanks to my mentors and co-authors at Desert Valley Hospital. #MedTwitter #InternalMedicine #Residency